216 related articles for article (PubMed ID: 15201503)
1. Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.
Jeong HS; Park KK; Park KK; Kim SP; Choi IJ; Lee IK; Kim HC
J Korean Med Sci; 2004 Jun; 19(3):374-83. PubMed ID: 15201503
[TBL] [Abstract][Full Text] [Related]
2. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.
Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC
J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction.
Isaka Y; Tsujie M; Ando Y; Nakamura H; Kaneda Y; Imai E; Hori M
Kidney Int; 2000 Nov; 58(5):1885-92. PubMed ID: 11044208
[TBL] [Abstract][Full Text] [Related]
4. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.
Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha.
Lindschau C; Quass P; Menne J; Güler F; Fiebeler A; Leitges M; Luft FC; Haller H
Hypertension; 2003 Sep; 42(3):335-41. PubMed ID: 12939231
[TBL] [Abstract][Full Text] [Related]
6. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
8. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.
Hsieh TJ; Chen R; Zhang SL; Liu F; Brezniceanu ML; Whiteside CI; Fantus IG; Ingelfinger JR; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1005-15. PubMed ID: 16528250
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
Marzo AL; Fitzpatrick DR; Robinson BW; Scott B
Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
12. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.
Gilbert RE; Wilkinson-Berka JL; Johnson DW; Cox A; Soulis T; Wu LL; Kelly DJ; Jerums G; Pollock CA; Cooper ME
Kidney Int; 1998 Oct; 54(4):1052-62. PubMed ID: 9767521
[TBL] [Abstract][Full Text] [Related]
13. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes.
Lane PH; Snelling DM; Hollman A; Langer WJ
Pediatr Nephrol; 2001 Dec; 16(12):1033-9. PubMed ID: 11793095
[TBL] [Abstract][Full Text] [Related]
14. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma.
Kim SG; Song JY
Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
17. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Akagi Y; Isaka Y; Arai M; Kaneko T; Takenaka M; Moriyama T; Kaneda Y; Ando A; Orita Y; Kamada T; Ueda N; Imai E
Kidney Int; 1996 Jul; 50(1):148-55. PubMed ID: 8807583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
